- Prospective observational study of 60 ASA I-II women undergoing elective total abdominal hysterectomy under general anesthesia, analyzed after six exclusions.
- Compared general anesthesia alone (n = 29) with general anesthesia plus adjunctive truncal regional block (n = 31).
- Richards-Campbell Sleep Questionnaire scores were higher with the block (73.0 ± 11.1 vs 47.9 ± 16.9; P < .001), and modified PSQI worsened only in the anesthesia-alone group (9.0 ± 2.4 to 11.7 ± 2.2; P < .001).
- Authors report lower pain scores and higher satisfaction with the block, and 12-hour VAS pain was the strongest predictor of postoperative PSQI (β = 0.56, P < .001).
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Prospective multicenter trial of 50 enrolled patients with chronic back and/or leg pain after lumbar spine surgery, of whom 32 completed 12-month activity follow-up.
- Baseline mobility was recorded with an accelerometer-equipped external stimulator, and permanent spinal cord stimulation followed if patients achieved at least 50% pain relief on trial.
- Mobility episodes of at least 30 seconds were 34±27 min/24 hours at baseline versus 92±51 min in healthy controls (p=0.009), and rose significantly only by 12 months (p=0.045).
- The increase was significant in leg-predominant pain (35±27 to 54±32 min, p=0.011) but not back-predominant pain, and mobility correlated with reduced disability (p=0.044) and leg pain (p=0.046).
- A cross-sectional study of 208 adults with cancer pain in a hospital-based palliative care setting used Neurometer quantitative sensory testing.
- Patients were grouped by opioid use and compared on current perception and pain thresholds for Aβ, Aδ, and C fibers, with age-adjusted analyses.
- Pain thresholds did not differ between groups, adjusted or unadjusted, and after age adjustment only Aβ current perception threshold differed significantly.
- The authors concluded that routine opioid use was not associated with clinically meaningful threshold changes, while cautioning about the cross-sectional design and residual confounding.
- Retrospective cohort study using VA Corporate Data Warehouse records of 30,462 veterans diagnosed with fibromyalgia, with comparisons of women and men.
- Nine co-occurring chronic overlapping pain conditions and use of nonpharmacological and pharmacological fibromyalgia treatments were compared by sex using logistic regression, unadjusted and adjusted.
- Women had higher adjusted odds of a co-occurring pain condition (aOR 1.17, 95% CI 1.11-1.23) and of multimodal treatment (aOR 1.29, 95% CI 1.19-1.40), but multimodal engagement was 9% to 12% overall.
- Women were also more often prescribed cyclobenzaprine and less often pregabalin, and the authors conclude that receipt of nonpharmacological treatments was low in both sexes.
- Retrospective observational comparative-effectiveness cohort of 90 patients with moderate-to-severe knee osteoarthritis, followed for 24 months.
- Compared cooled genicular radiofrequency ablation alone (n=50) with the same ablation plus intra-articular botulinum toxin type A (n=40), with a planned repeat BoNT-A injection at about 12 months in the combination group.
- Significant treatment-by-time interactions were found for NRS (ß=-0.84, 95% CI -1.21 to -0.47; P=0.0002) and WOMAC (ß=-6.3, 95% CI -9.4 to -3.2; P=0.0003).
- At 24 months, responder rates were 86.5% with combination therapy versus 51.1% with ablation alone (P=0.0004); the authors call for randomized trials to confirm this.
- A single-center retrospective study of 31 patients, with 162 serial blood samples drawn before pump refills during intrathecal bupivacaine for cancer pain.
- Serum bupivacaine concentration was examined against daily dose and infusion flow rate, with body mass index also assessed as a factor.
- Mean serum concentration was 167.7 µg/L (SD 266.2) at a mean daily dose of 39.5 mg/day (SD 31.4), and concentration rose with dose.
- Higher flow rates stayed independently associated with concentration after adjusting for dose, and the authors conclude exposure is well below the toxicity threshold.
- Cross-sectional study of 20 healthy, physically active, full-busted women assigned female at birth, recruited at a university research center in Houston.
- Self-reported neck, back, arm pain and mastalgia were compared with estradiol, progesterone, glycated hemoglobin, anthropometric measures, and mental health indicators.
- Musculoskeletal pain, anxiety, and depression were reported as significant (P < 0.005), and estradiol, progesterone, and glycated hemoglobin were significantly associated with pain, though no effect sizes are given.
- The authors conclude that hormonal and metabolic health influence pain and that covariates such as self-reported anxiety should be considered when examining pain mechanisms.
- This single-center cross-sectional study compared 101 adults with migraine against 101 age- and sex-matched controls using midsagittal FLAIR MRI.
- Corpus callosum genu, truncus, splenium thickness and length were measured by Witelson segmentation, then correlated with clinical measures within the migraine group.
- Migraine patients had thinner genu (10.41 vs 11.43 mm), truncus (5.91 vs 6.68 mm), and splenium (10.73 vs 11.13 mm), all P < 0.05, with no length difference.
- Genu thickness correlated with age at onset (r = 0.33), disability score (r = 0.37), and disease duration (r = -0.30), while attack frequency showed no association; the authors interpret this as cumulative remodeling.
- Single-center retrospective cohort of 382 patients with thoracic subacute herpetic neuralgia, propensity-matched into 72 pairs of burst-SCS and thoracic paravertebral block recipients.
- Burst spinal cord stimulation was compared with thoracic paravertebral block on pain, breakthrough pain, touch-evoked pain, sleep, and medication use over 12 months.
- Burst-SCS showed greater VAS improvement from discharge through 12 months, higher cure rates, and lower postherpetic neuralgia incidence at 3 months, though the abstract gives no effect sizes or CIs.
- Both procedures relieved pain and improved sleep, and the authors conclude burst-SCS had more favorable outcomes, with no difference in oral morphine equivalent dose.
- A retrospective cohort of 80 patients at a single academic pain center compared posterior interpositional (n=33) and lateral transiliac (n=47) SI joint fusion performed from 2020 to 2025.
- Both approaches were performed by interventional pain physicians, and the study compared short-term pain scores, blood loss, complications, and revision surgery between them.
- Both groups improved mean VAS from 6.6 cm to 3.4 cm at one month, but revision for loss of efficacy was 18.2% for posterior versus 0% for lateral (P = 0.003).
- The authors reported low blood loss and complication rates for both approaches and called for prospective, adequately powered studies to define long-term outcomes.
- Retrospective cohort of 149 patients with predominantly unilateral knee OA at a tertiary pain clinic in India, treated July 2023 to August 2025 and followed for 6 months.
- Compared intra-articular PRP (n=92) with nanofat (n=57), using NPRS pain scores and the 6-minute walk test measured via the Accupedo app.
- Nanofat gave greater, sustained pain relief (P < 0.01) and functional gain (P = 0.006) than PRP; ≥50% relief odds were non-significant (adjusted OR 2.05, 95% CI 0.92 to 4.58).
- Authors conclude nanofat gives greater, longer-lasting benefit but call for randomized trials, and link baseline varus deformity ≥5° to lower odds of significant pain relief.
- Retrospective analysis of FDA MAUDE adverse event reports from 2016 to 2025 for SynchroMed and Prometra intrathecal pumps, with 5,423 morphine-only and 1,072 morphine-bupivacaine reports.
- Compares intrathecal morphine monotherapy with a binary morphine-bupivacaine mixture, looking at dosing and device- and medication-related adverse events.
- The binary group received a higher median morphine dose (2.20 vs 1.50 mg/day) yet had less cognitive impairment (0.56% vs 1.48%, P < 0.05); granulomas trended lower (0.65% vs 1.33%, P = 0.068).
- The authors conclude that adding bupivacaine gives a safety profile similar to morphine alone, with less cognitive impairment and a trend toward fewer granulomas.
- A subsequent health economic analysis of previously published data from a 1-arm, multicenter study in the United States, with no control group.
- The exposure was use of an AI-powered digital self-management tool for chronic pain, and costs and QALYs were modeled from baseline to 6 and 12 weeks.
- At 12 weeks, the authors estimated $127 per user in reduced health care costs, $930 per user in increased annual productivity, and 0.0275 QALYs worth $1375.
- The authors conclude the tool shows potential savings of up to $2432 per person in total, or $7380 per year assuming 70% compliance, supporting it as a treatment alternative.
- Cross-sectional baseline analysis of 598 patients with lumbar spinal stenosis from two spine clinics, split into low (226) and high (108) recovery expectation groups.
- Network analysis compared associations among symptom duration and PROMIS-29 + 2 domains between the low and high expectation groups.
- The two networks showed no significant structural differences and stable strength centralities, and chronicity had no significant associations with other factors in either network.
- Pain interference and fatigue were the most influential factors in both groups, while anxiety was more influential in the low-expectation group.
- Multicenter retrospective cohort of 359 adults with vertebrogenic low back pain and Modic I or II changes who underwent BVNA at seven US centers from 2022 to 2025.
- Patients were grouped by radiofrequency lesion strategy: uniform 7-minute, uniform 15-minute, or mixed 7- and 15-minute lesions.
- Unadjusted ≥50% responder rates were 54.0%, 59.3%, and 73.5% (P = .005); after propensity weighting, mixed versus 15-minute OR was 2.01 (95% CI 0.88–4.59; P = .098).
- The authors found no statistically significant outcome differences across lesion strategies after adjustment, noted that male sex was linked to lower response, and called for prospective studies.
- Single-arm feasibility trial of 110 youth aged 10-18 with chronic pain who enrolled from 236 referrals at a tertiary pain clinic.
- A single-session Empowered Relief for Youth class, adapted from an adult program, teaches pain science and self-regulatory skills, with no comparator group.
- Over 80% rated the class credible, acceptable, and feasible, and pain interference, catastrophizing, and anxiety improved from baseline to 1 month and held through 3 months.
- An exploratory analysis linked greater pain interference improvement at 3 months to attending within 30 days of the clinic evaluation, which the authors call promising.
- Multicentre cohort of 604 CRPS patients (520 type I, 84 type II) who underwent DFNS quantitative sensory testing, using 13 parameters.
- Unsupervised, hypothesis-free cluster analysis was run on a training set (n=380) and checked in a validation set (n=224), rather than using predefined mechanistic subtypes.
- Three sensory phenotypes emerged: hypersensitivity to cold and heat pain (n=382), loss of thermal and mechanical sensation (n=200), and strong allodynia with mechanical hyperalgesia (n=22).
- The authors propose a bottom-up sensory stratification of CRPS that adds to mechanistic understanding when compared with human pain surrogate models.
- Retrospective cross-sectional study of active-duty service members in the US Military Health System, 2016–2021, with at least 24 months of continuous eligibility.
- Exposures were facility- and clinician-level characteristics at the index visit; outcomes were any nonpharmacological treatment and NPT before pharmacological treatment within 60 days.
- Forty percent received NPT within 60 days, rising from 39% in 2016 to 46% in 2021, and facility NPT personnel availability was associated with both outcomes.
- A physical therapist availability 1 SD above the mean corresponded to a 0.5% higher adjusted probability of each outcome; the authors suggest clinician availability as a modifiable barrier.
- This observational study surveyed 1048 Belgian community pharmacy patients using opioids for noncancer pain (64.4% female, mean age 59.0 years).
- There was no intervention or comparator; a structured questionnaire described patient profiles, opioid initiation and follow-up, and treatment experiences.
- Median pain intensity was 7 (IQR 2) on a 0-10 scale, nearly 30% received strong opioids, and about 40% attempted discontinuation, nearly half of them abruptly.
- Opioids were most often started for chronic low back pain, perceived need was high, and the authors highlight gaps in counseling and follow-up.
- Retrospective cohort of 3514 adults with traumatic spinal cord injury from the US Spinal Cord Injury Model Systems database, examining race/ethnicity, income, and education.
- Compared pain severity and severe pain interference across combinations of social disadvantage, with models adjusted for demographic and injury characteristics.
- Non-Hispanic Black, low-income, low-education participants had 2.43 points higher pain severity (95% CI 2.06-2.79) and 2.96-fold higher odds of severe pain interference (95% CI 2.15-4.07) than the most advantaged group.
- Mobility, days out of the house, private insurance, and perceived health status significantly mediated these disparities, which the authors propose as modifiable intervention targets.
- This review compares the trigeminal ganglion (head and face) with the dorsal root ganglion (body) across anatomy, embryology, cell composition, and molecular features.
- It also covers A/C fiber ratios, CNS connections, sympathetic sprouting, ectopic discharges, ion channel biophysics, and neuron-glia interactions.
- The authors suggest these differences may explain why the same stimuli or treatments can produce different responses in craniofacial versus somatic pain.
- They conclude that pain targets should be identified separately for each system and that craniofacial and somatic pain may need distinct therapeutic strategies.
- Observational study of 92 thalamic stroke patients (26 with CPSP) and 30 healthy controls, using DSI and resting-state fMRI to map brain networks.
- Structural and functional networks were built and compared between CPSP and non-CPSP patients using graph theory measures.
- CPSP patients had higher clustering and efficiency, lower path length, and lower structure-function coupling (PBonferroni<0.05); pain severity correlated with several network measures (PAdjusted<0.05).
- The authors propose structural reorganization and structure-function decoupling as a possible mechanism for CPSP, with potential for network-based biomarkers and neuromodulation targets.
- Registry-based study of 1263 patients starting PAD care at 16 vascular centers in the U.S., the Netherlands, and Australia (2011–2015).
- Exposures were PAD severity (resting ABI, Rutherford stage) and depressive symptoms, anxiety, and perceived stress, compared against frequent, intense, sleep-interfering, and chronic pain.
- Psychological factors were linked to frequent, intense, and sleep-interfering pain (ORs 1.58–5.09), with depressive symptoms the strongest correlate, while resting ABI showed no association.
- Over 80% reported heightened pain, and the authors conclude that claudication pain reflects both vascular and psychological dimensions, supporting integrated biopsychosocial assessment.
- This observational cohort study followed 493 people with HIV across 6 US sites, all free of distal neuropathic pain at entry.
- Pain was assessed with a standardized clinician-administered instrument at semiannual visits, and predictors were evaluated with mixed-effects logistic regression.
- Twenty-seven percent (131 of 493) developed new distal neuropathic pain over a median follow-up of 24 months; older age, female sex, antiretroviral treatment, and lack of viral suppression predicted onset.
- Lifetime opioid use disorder predicted onset, and more severe depressive symptoms during follow-up were also linked to higher risk, which the authors connect to neuropsychiatric influences.
- This fMRI study of 60 healthy participants used psychophysiological interaction analysis to compare how low and high experimental pain changed periaqueductal gray connectivity in men and women.
- Connectivity was compared between exposure to low-intensity and high-intensity experimental pain.
- Pain thresholds did not differ by sex, and in both sexes PAG connectivity with somatosensory cortex, supplementary motor area, cerebellum and thalamus increased during high pain.
- Only 26 men, not women, showed a pain-induced rise in PAG connectivity with amygdala, caudate and putamen, hinting at sex-specific endogenous pain inhibition.
- Structural equation modeling of 921 HIV-seropositive and 1019 HIV-seronegative gay/bisexual men in the prospective MACS cohort, using six years of repeated measures.
- Pain was the central variable, linking sociodemographics, HIV status and CD4 count to depressive symptoms and illicit drug use.
- Pain predicted more cannabis, cocaine and heroin use and more depressive symptoms, and the path models were similar by HIV status; no effect sizes are reported.
- HIV-seropositive status predicted more inhaled nitrite use, and lower CD4 counts, African American race, less education and older age were linked to more pain. The authors call for better pain management in vulnerable subgroups.
- In vitro study of dental pulp biopsies from patients undergoing extraction of normal wisdom teeth; sample size is not stated in the abstract.
- Capsaicin was applied to superfused pulp tissue, and released immunoreactive CGRP was measured by enzyme immunoassay, with vehicle as comparator.
- Capsaicin raised CGRP release in a concentration-dependent manner; this was calcium-dependent, blocked by a TRPV1 antagonist, and reduced by acute and repeated capsaicin exposure.
- PMA increased basal and stimulated release, and PGE2 pretreatment made DAMGO able to inhibit capsaicin-stimulated release, which the authors present as a tool for testing compounds on human nociceptor sensitivity.
- Retrospective analysis of World Mental Health Surveys data (N=18,309) using Cox proportional hazard models to examine childhood adversity and early-onset psychological disorder as predictors of adult-onset arthritis.
- Exposure was the number of childhood adversities compared with none, plus presence of early-onset psychological disorder, with models adjusted for age, sex, and early-onset mental disorder.
- Two childhood adversities were associated with higher arthritis risk (HR=1.27, 95% CI 1.08-1.50), and three or more with HR=1.44 (95% CI 1.24-1.67).
- Early-onset depressive and/or anxiety disorder was associated with increased arthritis risk after adjusting for adversities (HR=1.43, 95% CI 1.28-1.61); authors suggest prospective studies assess multiple chronic outcomes.
- Preclinical study in male rats with L5-L6 spinal nerve ligation, combining behavior testing, LC immunohistochemistry, and spinal dorsal horn microdialysis; sample sizes are not given in the abstract.
- Gabapentin was given intra-locus coeruleus or systemically, with CNQX (an AMPA antagonist) and intrathecal idazoxan (an alpha2-adrenoceptor antagonist) used to probe the pathway.
- Gabapentin increased pCREB-expressing LC nuclei in slices and in animals, an effect abolished by CNQX, and intra-LC gabapentin reduced hypersensitivity in a dose-dependent manner.
- The authors conclude that gabapentin acts directly in the brainstem through a glutamate-dependent mechanism that engages descending inhibition after peripheral nerve injury.
- Preclinical study in rats and mice given sustained morphine over 6 days, examining hyperalgesia and spinal dorsal horn changes.
- Morphine-treated animals were compared with placebo, and an NK-1 receptor antagonist and NK-1 knockout mice were used to test the receptor's role.
- Sustained morphine produced hyperalgesia and increased spinal substance P and NK-1 receptor expression, with broader NK-1 receptor internalization; the antagonist reversed hyperalgesia and knockout mice did not develop it.
- The authors conclude that NK-1 receptors are critical for sustained morphine-induced hyperalgesia, which resembles changes seen in inflammatory pain.
- A double-blind crossover study in 77 volunteers compared a 40-minute 38% nitrous oxide exposure with placebo gas, using electrical tooth stimulation.
- A second double-blind experiment in 64 volunteers gave repeated 30-minute 35% nitrous oxide sessions across five visits, with a 16-person placebo-only control group.
- In the first experiment, acute tolerance developed for pain threshold but not detection threshold, and no hyperalgesic rebound followed cessation of the gas.
- In the second experiment, acute and chronic tolerance developed for both threshold measures, while a test for Pavlovian conditioning found no conditioned effects on sensory thresholds.
- In 148 subjects (87 female, 61 male), thermal pain testing was paired with a questionnaire on gender role expectations of pain.
- The exposure was each participant's Gender Role Expectations of Pain score, examined alongside sex as a predictor of experimental pain measures.
- After controlling for age, GREP scores predicted threshold, tolerance, and unpleasantness, adding 7%, 11%, and 21% of variance; sex still predicted tolerance after adjustment.
- The authors conclude that psychosocial expectations and biological sex both remain plausible explanations for sex differences in laboratory pain reports.